Fresenius Medical Care AG

Equities

FME

DE0005785802

Healthcare Facilities & Services

Real-time Estimate Tradegate 03:20:07 2024-02-22 am EST 5-day change 1st Jan Change
35.42 EUR -0.56% Intraday chart for Fresenius Medical Care AG -8.38% -6.35%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Health Care Down on a Mixed Growth View -- Health Care Roundup DJ
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Gets a Neutral rating from UBS ZD
European Equities Traded in the US as American Depositary Receipts Trend Lower in Wednesday Trading MT
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Deutsche Bank gives a Neutral rating ZD
SA's Competition Tribunal OKs Life Healthcare / Fresenius Medical Care's Unit Deal With Conditions RE
FRESENIUS MEDICAL CARE : Barebone 2023 profitability is a much lower starting point Alphavalue
U.S. Futures Fall, European Stocks Mixed DJ
Germany's Fresenius Forecasts Revenue Growth in FY24 MT
Fresenius: 13% drop in annual net profit CF
Healthcare group Fresenius tops Q4 operating profit expectations RE
EMEA Morning Briefing : Fed Minutes, Nvidia Results Eyed DJ
FRESENIUS MEDICAL CARE : Things are on track, but not all is good Alphavalue
Fresenius Medical Care CEO Foresees Neutral Impact of Obesity Medicines on Dialysis Sector MT
Transcript : Fresenius Medical Care AG & Co. KGaA, Q4 2023 Earnings Call, Feb 20, 2024
Fresenius Medical Care AG Proposes Dividend for the Fiscal Year 2023 CI
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Receives a Sell rating from Warburg Research ZD
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Barclays remains Neutral ZD
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Bernstein sticks Neutral ZD
Fresenius Medical Care AG Provides Earnings Guidance for Fiscal Year 2024 CI
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Jefferies keeps a Sell rating ZD
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Berenberg reiterates its Buy rating ZD
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : UBS remains Neutral ZD
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : JP Morgan reaffirms its Sell rating ZD
European Midday Briefing : Stocks Struggle Despite China's Latest Easing Attempt DJ
Fresenius MedCare: EPS up 4% in 2023 CF
Chart Fresenius Medical Care AG
More charts
Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
20
Last Close Price
35.62 EUR
Average target price
40.75 EUR
Spread / Average Target
+14.40%
Consensus
  1. Stock
  2. Equities
  3. Stock Fresenius Medical Care AG - Xetra
  4. News Fresenius Medical Care AG
  5. European Equities Traded in the US as American Depositary Receipts Trend Lower Thursday
+229% on MICROSOFT CORPORATION since our purchase on January 11, 2019
Replicate our performance
fermer